Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model

The link model is a fundamental pharmacokinetic-pharmacodynamic (PK–PD) approach to account for delayed drug responses when the observed effect does not immediately correlate with the drug's plasma concentration peak. This delay is mathematically addressed by introducing an effect compartment concentration, C_e, which is kinetically linked to the plasma concentration, C_p, via a first-order rate constant, k_e0. The linkage allows for a more accurate prediction of drug effects over time. A higher k_e0 value means rapid equilibration between C_p and C_e, aligning the effect site closely with the plasma profile. On the other hand, a lower k_e0 means slower equilibration, causing the drug's observed effect to lag behind the plasma concentration curve.

The time-dependent relationship between drug plasma concentrations and effects often results in hysteresis loops in concentration–response plots. An anticlockwise hysteresis loop, typical of many drugs, points to a delayed effect relative to plasma concentration. However, drugs like fentanyl and cocaine show clockwise hysteresis, reflecting tolerance or receptor desensitization mechanisms over time. These graphical patterns offer insights into the dynamics of drug interactions and receptor binding.

Systems pharmacodynamic models incorporate equations accounting for homeostasis and feedback to model complex biological systems. These models extend beyond single-compartment link dynamics to evaluate interrelated physiological processes, enabling predictions of systemic responses to pharmacological interventions. They are robust tools for understanding how alterations in one biological pathway influence the entire system, making them indispensable for optimizing drug development and therapeutic strategies.